Critical Needs in Advancing Shigella Vaccines for Global Health-Reference-Cited by-同舟云学术

Critical Needs in Advancing Shigella Vaccines for Global Health

Published:2021-09-24 Issue: Volume: Page:
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

MacLennan Calman A¹^ORCID,Talaat Kawsar R²,Kaminski Robert W³,Cohen Dani⁴,Riddle Mark S⁵,Giersing Birgitte K⁶

Affiliation:

1. Bill & Melinda Gates Foundation, London, United Kingdom

2. Center for Immunization Research, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

3. Diarrheal Disease Research, Bacterial Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA

4. School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

5. University of Nevada, Reno School of Medicine, Reno, Nevada, USA

6. World Health Organization, Geneva, Switzerland

Abstract

Advancing new O-antigen-based Shigella vaccines is critically dependent on development of an international standard serum and harmonized ELISA, demonstration of field efficacy in young children in low- and middle-income countries, and early engagement with regulators and policy makers.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiab462/40597046/jiab462.pdf

Reference24 articles.

1. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017;GBD;Lancet,2018

2. Shigella isolates from the global enteric multicenter study inform vaccine development;Livio;Clin Infect Dis,2014

3. Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults;Cohen;Lancet,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shigella Vaccines: The Continuing Unmet Challenge;International Journal of Molecular Sciences;2024-04-13

2. Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries;The Lancet Global Health;2023-11

3. Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries;The Lancet Global Health;2023-11

4. Consequences of Shigella infection in young children: a systematic review;International Journal of Infectious Diseases;2023-04

5. A Shigella flexneri 2a synthetic glycan-based vaccine induces a long-lasting immune response in adults;npj Vaccines;2023-03-10